GLP-1 RA = glucagon-like peptide-1 receptor agonist; PBS = Pharmaceutical Benefits Scheme; T2DM = Type 2 diabetes mellitus

Privacy Policy    |    Terms of Service    |    Contact Us

Ozempic^® is a registered trademark of Novo Nordisk A/S. Novo Nordisk Pharmaceuticals Pty. Ltd. Please review full PI before prescribing. Full PI is available from
www.novonordisk.com.au or click here. Further information is available on request from Novo Nordisk. Level 10, 118 Mount Street, North Sydney, NSW, 2060. ABN 40 002 879 996. NovaCare^® Customer Care Centre (Australia) 1800 668 626. https://www.novonordisk.com.au. Date of preparation: January 2022. AU22OZM00001